Your browser doesn't support javascript.
loading
Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis.
Tardieu, Mathilde; Néron, Amélie; Duvert-Lehembre, Sophie; Amine Larabi, Islam; Barkaoui, Mohamed; Emile, Jean-Francois; Seigneurin, Arnaud; Boralevi, Franck; Donadieu, Jean.
Afiliação
  • Tardieu M; Pediatric Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France.
  • Néron A; Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France.
  • Duvert-Lehembre S; Dermatology Department, Lille University Hospital, Lille, France.
  • Amine Larabi I; Department of Pharmacology and Toxicology, Paris-Saclay University (Versailles Saint-Quentin-en-Yvelines University), Inserm U-1173, Raymond Poincaré Hospital, Garches, France.
  • Barkaoui M; French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France.
  • Emile JF; Pathology Department & EA4340-BECCOH, Ambroise Paré Hospital, AP-HP & Versailles SQY University, Boulogne, France.
  • Seigneurin A; TIMC-IMAG Laboratory, Grenoble Alpes University, Grenoble Alpes University Hospital, Grenoble, France.
  • Boralevi F; Pediatric Dermatology Unit, Hôpital Pellegrin-Enfants, Bordeaux, France.
  • Donadieu J; French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France.
Pediatr Blood Cancer ; 68(9): e29140, 2021 09.
Article em En | MEDLINE | ID: mdl-34109735
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Histiocitose de Células de Langerhans / Vemurafenib Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Histiocitose de Células de Langerhans / Vemurafenib Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article